Business Description
Nephro Care India Ltd
SIC : 8092
ISIN : INE0SUN01013
Total Employee Number:
334Compare
Compare
Traded in other countries / regions
NEPHROCARE.India IPO Date
2024-07-05Description
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.77 | |||||
Beneish M-Score | -1.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 70.4 | |||||
3-Year EBITDA Growth Rate | 43.7 | |||||
3-Year EPS without NRI Growth Rate | 19.6 | |||||
3-Year Book Growth Rate | 185.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.5 | |||||
9-Day RSI | 54.19 | |||||
14-Day RSI | 55.57 | |||||
3-1 Month Momentum % | 14.35 | |||||
6-1 Month Momentum % | 19.36 | |||||
12-1 Month Momentum % | -46.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.02 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 1.08 | |||||
Days Inventory | 48.99 | |||||
Days Sales Outstanding | 38.77 | |||||
Days Payable | 134.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.42 | |||||
Operating Margin % | -6.94 | |||||
Net Margin % | 3.28 | |||||
EBITDA Margin % | 11.17 | |||||
FCF Margin % | -12.89 | |||||
OCF Margin % | 5.09 | |||||
ROE % | 2.58 | |||||
ROA % | 2.06 | |||||
ROIC % | -4.96 | |||||
3-Year ROIIC % | -7.38 | |||||
ROC (Joel Greenblatt) % | 5.52 | |||||
ROCE % | 3.37 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 107.76 | |||||
PE Ratio without NRI | 107.76 | |||||
PEG Ratio | 0.66 | |||||
PS Ratio | 3.52 | |||||
PB Ratio | 2.71 | |||||
Price-to-Tangible-Book | 2.72 | |||||
Price-to-Operating-Cash-Flow | 70.01 | |||||
EV-to-EBIT | 73.19 | |||||
EV-to-EBITDA | 28.47 | |||||
EV-to-Revenue | 3.18 | |||||
EV-to-FCF | -24.52 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.84 | |||||
Price-to-Graham-Number | 3.61 | |||||
| Price-to-Net-Current-Asset-Value | 10.35 | |||||
| Price-to-Net-Cash | 240.38 | |||||
Earnings Yield (Greenblatt) % | 1.36 | |||||
FCF Yield % | -3.62 | |||||
Forward Rate of Return (Yacktman) % | 16.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nephro Care India Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 434.085 | ||
| EPS (TTM) (₹) | 0.87 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 97.48 | ||
| 14-Day RSI | 55.57 | ||
| 14-Day ATR (₹) | 6.27863 | ||
| 20-Day SMA (₹) | 93.8225 | ||
| 12-1 Month Momentum % | -46.83 | ||
| 52-Week Range (₹) | 50.05 - 156.35 | ||
| Shares Outstanding (Mil) | 16.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nephro Care India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nephro Care India Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nephro Care India Ltd Frequently Asked Questions
What is Nephro Care India Ltd(NSE:NEPHROCARE)'s stock price today?
The current price of NSE:NEPHROCARE is ₹93.75. The 52 week high of NSE:NEPHROCARE is ₹156.35 and 52 week low is ₹50.05.
When is next earnings date of Nephro Care India Ltd(NSE:NEPHROCARE)?
The next earnings date of Nephro Care India Ltd(NSE:NEPHROCARE) is .
Does Nephro Care India Ltd(NSE:NEPHROCARE) pay dividends? If so, how much?
Nephro Care India Ltd(NSE:NEPHROCARE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers